153 related articles for article (PubMed ID: 17491682)
21. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice.
Rohane PW; Shimada A; Kim DT; Edwards CT; Charlton B; Shultz LD; Fathman CG
Diabetes; 1995 May; 44(5):550-4. PubMed ID: 7729614
[TBL] [Abstract][Full Text] [Related]
22. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
23. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.
Gerling IC; Serreze DV; Christianson SW; Leiter EH
Diabetes; 1992 Dec; 41(12):1672-6. PubMed ID: 1446808
[TBL] [Abstract][Full Text] [Related]
24. Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model.
Marzo N; Ortega S; Stratmann T; García A; Ríos M; Giménez A; Gomis R; Mora C
J Immunol; 2008 Jan; 180(2):1189-98. PubMed ID: 18178859
[TBL] [Abstract][Full Text] [Related]
25. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage.
Amrani A; Jafarian-Tehrani M; Mormède P; Durant S; Pleau JM; Haour F; Dardenne M; Homo-Delarche F
J Endocrinol; 1996 Jan; 148(1):139-48. PubMed ID: 8568461
[TBL] [Abstract][Full Text] [Related]
27. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice.
Wicker LS; Miller BJ; Mullen Y
Diabetes; 1986 Aug; 35(8):855-60. PubMed ID: 3525284
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.
Rapoport MJ; Jaramillo A; Zipris D; Lazarus AH; Serreze DV; Leiter EH; Cyopick P; Danska JS; Delovitch TL
J Exp Med; 1993 Jul; 178(1):87-99. PubMed ID: 8315397
[TBL] [Abstract][Full Text] [Related]
29. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic islet ganglioside expression in nonobese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune beta-cell destruction.
Dotta F; Peterson LB; Previti M; Metzger J; Tiberti C; Anastasi E; Zoppitelli P; Wicker LS; Di Mario U
Endocrinology; 1992 Jan; 130(1):37-42. PubMed ID: 1727711
[TBL] [Abstract][Full Text] [Related]
31. Insulin-producing intestinal K cells protect nonobese diabetic mice from autoimmune diabetes.
Mojibian M; Lam AW; Fujita Y; Asadi A; Grassl GA; Dickie P; Tan R; Cheung AT; Kieffer TJ
Gastroenterology; 2014 Jul; 147(1):162-171.e6. PubMed ID: 24662331
[TBL] [Abstract][Full Text] [Related]
32. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice.
Greeley SA; Katsumata M; Yu L; Eisenbarth GS; Moore DJ; Goodarzi H; Barker CF; Naji A; Noorchashm H
Nat Med; 2002 Apr; 8(4):399-402. PubMed ID: 11927947
[TBL] [Abstract][Full Text] [Related]
33. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
Füchtenbusch M; Larger E; Thebault K; Boitard C
Horm Metab Res; 2005 Feb; 37(2):63-7. PubMed ID: 15778920
[TBL] [Abstract][Full Text] [Related]
34. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.
Chen W; Bergerot I; Elliott JF; Harrison LC; Abiru N; Eisenbarth GS; Delovitch TL
J Immunol; 2001 Nov; 167(9):4926-35. PubMed ID: 11673498
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse.
Zekzer D; Wong FS; Wen L; Altieri M; Gurlo T; von Grafenstein H; Sherwin RS
Diabetes; 1997 Jul; 46(7):1124-32. PubMed ID: 9200646
[TBL] [Abstract][Full Text] [Related]
36. The postnatal maternal environment influences diabetes development in nonobese diabetic mice.
Washburn LR; Dang H; Tian J; Kaufman DL
J Autoimmun; 2007 Feb; 28(1):19-23. PubMed ID: 17207966
[TBL] [Abstract][Full Text] [Related]
37. Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse.
Beauquis J; Saravia F; Coulaud J; Roig P; Dardenne M; Homo-Delarche F; De Nicola A
Exp Neurol; 2008 Apr; 210(2):359-67. PubMed ID: 18190910
[TBL] [Abstract][Full Text] [Related]
38. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
[TBL] [Abstract][Full Text] [Related]
39. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice.
Gysemans CA; Cardozo AK; Callewaert H; Giulietti A; Hulshagen L; Bouillon R; Eizirik DL; Mathieu C
Endocrinology; 2005 Apr; 146(4):1956-64. PubMed ID: 15637289
[TBL] [Abstract][Full Text] [Related]
40. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice.
Itoh N; Imagawa A; Hanafusa T; Waguri M; Yamamoto K; Iwahashi H; Moriwaki M; Nakajima H; Miyagawa J; Namba M; Makino S; Nagata S; Kono N; Matsuzawa Y
J Exp Med; 1997 Aug; 186(4):613-8. PubMed ID: 9254659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
